- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Carnitine Metabolism Disturbances in Australia
Total 1703 results
-
Kepler University HospitalCompleted
-
Daré Bioscience, Inc.Active, not recruitingDysmenorrhea PrimaryAustralia
-
University of AdelaideUnknownChronic Pain | Pelvic Pain | DysmenorrhoeaAustralia
-
BayerRecruitingSleep Disturbances Associated With MenopauseUnited States, Belgium, Austria, Czechia, Germany, Netherlands, Poland, Spain
-
Family Planning Association New South WalesMerck Sharp & Dohme LLCUnknown
-
RDC Clinical Pty LtdRecruiting
-
AstraZenecaCompletedMetabolic Syndrome | DyslipidemiaAustralia
-
HiPP GmbH & Co. Vertrieb KGCharite University, Berlin, GermanyCompletedDisturbance of GrowthGermany, Austria, Serbia
-
The University of Western AustraliaNational Heart Foundation, AustraliaCompletedObesity | Cardiovascular Disease | Lipid DisordersAustralia
-
University of AdelaideCompletedInsulin ResistanceAustralia
-
Swisse Wellness Pty LtdCommonwealth Scientific & Industrial Research Organisation; BIONAP SRLCompletedInvestigating Effects of a Novel Nutraceutical on Hypercholesterolaemia in Australian Adults (CLoNE)HypercholesterolemiaAustralia
-
University of AdelaideRoyal Adelaide Hospital; University of South AustraliaTerminatedInsulin ResistanceAustralia
-
Evopoint Biosciences Inc.Completed
-
HighTide Biopharma Pty LtdCompletedHypercholesterolemiaAustralia
-
The University of Western AustraliaCompletedObesity | Insulin Resistance | DyslipidemiaAustralia
-
The University of Western AustraliaNational Health and Medical Research Council, AustraliaUnknownFamilial Hypercholesterolaemia | HypertriglyceridaemiaAustralia
-
Sydney Centre for Reproductive Health ResearchMerck Sharp & Dohme LLCUnknown
-
Medical University of ViennaCompleted
-
University of South AustraliaAmerican Egg BoardCompletedHypercholesterolemia | Hyperlipidemias | Diet, Healthy | Physical InactivityAustralia
-
The University of Western AustraliaCompletedObesity | Insulin Resistance | DyslipidemiaAustralia
-
AmgenCompletedPrimary Hyperlipidemia and Mixed DyslipidemiaAustralia
-
University of AdelaideCompletedDiabetes | Metabolic SyndromeAustralia
-
AstraZenecaCompletedMetabolic Syndrome | DyslipidemiaAustralia
-
Chong Kun Dang PharmaceuticalCompleted
-
University of AdelaideCompletedInsulin Resistance | Type 2 DiabetesAustralia
-
The University of Western AustraliaUnknown
-
NestléCompletedPhenylketonuriaAustralia, Germany
-
LipimetiX Development, LLCCompletedHypercholesterolemia | Hyperlipoproteinemia Type IIAustralia
-
University of AdelaideCompletedObesity | Type 2 DiabetesAustralia
-
University of AdelaideCompletedObesity | Type 2 DiabetesAustralia
-
Marea TherapeuticsRecruiting
-
Bond BiosciencesTerminatedHereditary HemochromatosisAustralia
-
ModernaTX, Inc.RecruitingPhenylketonuriaUnited States, Australia
-
University of AdelaideSalk Institute for Biological StudiesTerminatedInsulin Resistance | Type2 DiabetesAustralia
-
Mondelēz International, Inc.University of SydneyCompletedMetabolism and Nutrition DisordersAustralia
-
PDC Biotech GmbHCompleted
-
University of AdelaideAustralasian Hyperbaric & Diving Medicine Research TrustCompletedOverweight and Obesity | Insulin SensitivityAustralia
-
Royal Perth HospitalRecruitingObesity | Type 2 Diabetes Mellitus | Metabolic SyndromeAustralia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Australia
-
University of AdelaideCompletedIndividuals at Risk of Developing DiabetesAustralia
-
Western Sydney Local Health DistrictCompletedMetabolic Syndrome | HypercholesterolemiaAustralia
-
Baker Heart Research InstituteNational Heart Foundation, AustraliaUnknownMetabolic SyndromeAustralia
-
The University of Western AustraliaKing Edward Memorial HospitalCompletedGestational Diabetes MellitusAustralia
-
Menzies Institute for Medical ResearchDeakin UniversityActive, not recruiting
-
Zosano Pharma CorporationCompleted
-
Kirby InstituteNational Heart, Lung, and Blood Institute (NHLBI); The University of New South... and other collaboratorsCompletedHIV Infections | Cardiovascular Disease | Lipodystrophy | Glucose Metabolism | Lipid Metabolism | Metabolic AbnormalityAustralia
-
Orphatech Pharmaceuticals, GmbHWithdrawnMolybdenum Cofactor Deficiency Type AAustralia
-
University of AdelaideSalk Institute for Biological Studies; University of South AustraliaCompletedObesity | Type2 DiabetesAustralia
-
Garvan Institute of Medical ResearchCompleted
-
The George InstitutePfizer; Royal Prince Alfred Hospital, Sydney, Australia; Lipid and Cardiovascular... and other collaboratorsCompletedHypercholesterolemiaAustralia